Intramedullary Spinal Cord Tumors and Inflammatory Demyelinating Lesions study dataset
2026-01-24https://doi.org/10.1148/atlas.1769273106231
50
Overview
Schema Version
https://atlas.rsna.org/schemas/2025-11/dataset.json
Name
Intramedullary Spinal Cord Tumors and Inflammatory Demyelinating Lesions study dataset
Link
https://dx.doi.org/10.1148/ryai.210292
Indexing
Keywords: Spinal cord, Intramedullary, Astrocytoma, Ependymoma, Multiple sclerosis, NMOSD, Deep learning, Segmentation, Classification, T2-weighted MRI
Content: NR, MR
RadLex: RID4066, RID4033, RID19284, RID35613, RID7395
SNOMED: 1157043006, 1186904005, 443643007, 24700007
Author(s)
Zhizheng Zhuo
Jie Zhang
Yunyun Duan
Liying Qu
Chenlu Feng
Xufang Huang
Dan Cheng
Xiaolu Xu
Ting Sun
Zhaohui Li
Xiaopeng Guo
Xiaodong Gong
Yongzhi Wang
Wenqing Jia
Decai Tian
Xinghu Zhang
Fudong Shi
Sven Haller
Frederik Barkhof
Chuyang Ye
Yaou Liu
Organization(s)
Beijing Tiantan Hospital, Capital Medical University
BioMind
Neusoft Group, Department of Medical Imaging Product
China National Clinical Research Center for Neurologic Diseases
Tianjin Neurologic Institute, Tianjin Medical University General Hospital
University Hospitals of Geneva and University of Geneva, Department of Imaging and Medical Informatics
UCL Institutes of Neurology and Healthcare Engineering
Amsterdam University Medical Centers, Department of Radiology and Nuclear Medicine
Beijing Institute of Technology, School of Information and Electronics
License
Text: © 2022 by the Radiological Society of North America, Inc.
Contact
Corresponding author: Yaou Liu (contact email provided in article text)
Funding
National Science Foundation of China (81870958, 81571631); Beijing Municipal Natural Science Foundation for Distinguished Young Scholars (JQ20035); Special Fund of the Pediatric Medical Coordinated Development Center of Beijing Hospitals Authority (XTYB201831); ECTRIMS-MAGNMIS Fellowship from ECTRIMS (Y.L.).
Ethical review
Study performed in accordance with the Declaration of Helsinki and approved by the animal and human ethics committee of the local institution; written informed consent was obtained from all patients.
Comments
Retrospective development cohort (n=490) and prospective test cohort (n=157) of patients with intramedullary spinal cord lesions used to develop and evaluate a DL pipeline for segmentation and classification using sagittal T2-weighted MRI.
Date
Published: 2022-09-07
References
[1] Zhuo Z, Zhang J, Duan Y, et al.. "Automated Classification of Intramedullary Spinal Cord Tumors and Inflammatory Demyelinating Lesions Using Deep Learning". Radiology: Artificial Intelligence. 2022-11-01. doi:10.1148/ryai.210292. PMID: 36523644. PMCID: PMC9745442.
Dataset
Motivation
To develop a deep learning pipeline for integrated segmentation and differential diagnosis of intramedullary spinal cord tumors and inflammatory demyelinating lesions using widely available T2-weighted MRI.
Sampling
Retrospective identification of consecutive patients prior to treatment (2012–2018) and prospective consecutive enrollment (2019–2020) according to inclusion/exclusion criteria.
Partitioning scheme
Retrospective cohort (2012–2018) split into training (80%) and validation (20%); independent prospective test cohort (2019–2020).
Missing information
Exact imaging file formats, acquisition parameters, and per-partition class distributions for the retrospective training and validation splits are not reported in the main text.
Confidentiality
Clinical MRI with patient health information; data sharing by request from the corresponding author.
Sensitive data
Clinical imaging data of patients with spinal cord diseases.